Page last updated: 2024-10-29

isoniazid and Acute Confusional Senile Dementia

isoniazid has been researched along with Acute Confusional Senile Dementia in 5 studies

Hydra: A genus of freshwater polyps in the family Hydridae, order Hydroida, class HYDROZOA. They are of special interest because of their complex organization and because their adult organization corresponds roughly to the gastrula of higher animals.
hydrazide : Compounds derived from oxoacids RkE(=O)l(OH)m (l =/= 0) by replacing -OH by -NRNR2 (R groups are commonly H). (IUPAC).

Research Excerpts

ExcerptRelevanceReference
"Deferoxamine treatment may produce serious side effects that can be eliminated by modification of treatment and by control of deferoxamine metabolism."1.28Suppression of deferoxamine mesylate treatment-induced side effects by coadministration of isoniazid in a patient with Alzheimer's disease subject to aluminum removal by ionspecific chelation. ( Fisher, EA; Kruck, TP; McLachlan, DR, 1990)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Santos, DC1
Henriques, RR1
Junior, MAAL1
Farias, AB1
Nogueira, TLDC1
Quimas, JVF1
Romeiro, NC1
Silva, LLD1
Souza, ALF1
Nam, G1
Suh, JM1
Yi, Y1
Lim, MH1
De Falco, A1
Kincheski, GC1
Atrián-Blasco, E1
Hureau, C1
Ferreira, ST1
Rey, NA2
Hauser-Davis, RA1
de Freitas, LV1
Cukierman, DS1
Cruz, WS1
Miotto, MC1
Landeira-Fernandez, J1
Valiente-Gabioud, AA1
Fernández, CO1
Kruck, TP1
Fisher, EA1
McLachlan, DR1

Other Studies

5 other studies available for isoniazid and Acute Confusional Senile Dementia

ArticleYear
Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.
    Bioorganic & medicinal chemistry, 2020, 05-15, Volume: 28, Issue:10

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Biphenyl Compounds; Chelating Agents

2020
Drug repurposing: small molecules against Cu(II)-amyloid-β and free radicals.
    Journal of inorganic biochemistry, 2021, Volume: 224

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Copper; Drug Repositioning; Free Radicals; Humans; Hydrazi

2021
The aroylhydrazone INHHQ prevents memory impairment induced by Alzheimer's-linked amyloid-β oligomers in mice.
    Behavioural pharmacology, 2020, Volume: 31, Issue:8

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Disease Mo

2020
Disruption of zinc and copper interactions with Aβ(1-40) by a non-toxic, isoniazid-derived, hydrazone: a novel biometal homeostasis restoring agent in Alzheimer's disease therapy?
    Metallomics : integrated biometal science, 2015, Volume: 7, Issue:5

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Copper; Homeostasis; Humans;

2015
Suppression of deferoxamine mesylate treatment-induced side effects by coadministration of isoniazid in a patient with Alzheimer's disease subject to aluminum removal by ionspecific chelation.
    Clinical pharmacology and therapeutics, 1990, Volume: 48, Issue:4

    Topics: Aluminum; Alzheimer Disease; Chelation Therapy; Chromatography, High Pressure Liquid; Deferoxamine;

1990